D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
PUT
Align Technology
ALGN
$12B
| $5.48M | ﹤0.01% |
20,000
| – | – |
|
1702
PUT
Air Products & Chemicals
APD
$65.2B
| $5.48M | ﹤0.01% |
+20,000
| New | +$5.5M |
|
|
VRN
1703
DELISTED
Veren
VRN
| $5.47M | ﹤0.01% |
788,891
-103,200
| -12% | -$761K |
|
1704
PUT
OneMain Financial
OMF
$7.08B
| $5.46M | ﹤0.01% |
111,000
+20,000
| +22% | +$816K |
|
1705
PUT
Madison Square Garden
MSGS
$9.57B
| $5.45M | ﹤0.01% |
30,000
+2,100
| +8% | +$364K |
|
1706
CALL
Kohl's
KSS
$2.1B
| $5.44M | ﹤0.01% |
189,800
-2,500
| -1% | -$58.6K |
|
1707
PUT
Live Nation Entertainment
LYV
$41.7B
| $5.43M | ﹤0.01% |
58,000
+13,700
| +31% | +$1.18M |
|
1708
PUT
Teradyne
TER
$52.4B
| $5.43M | ﹤0.01% |
50,000
| – | – |
|
1709
Bank OZK
OZK
$5.5B
| $5.42M | ﹤0.01% |
108,799
+68,872
| +172% | +$2.84M |
|
1710
Accuray
ARAY
$26.8M
| $5.42M | ﹤0.01% |
1,915,585
-533,116
| -22% | -$1.45M |
|
1711
CALL
Franco-Nevada
FNV
$41.4B
| $5.42M | ﹤0.01% |
48,900
-40,100
| -45% | -$4.88M |
|
|
GAP
1712
CALL
The Gap Inc
GAP
$7.07B
| $5.41M | ﹤0.01% |
258,800
-71,200
| -22% | -$1.15M |
|
1713
PUT
Zillow
Z
$7.32B
| $5.41M | ﹤0.01% |
93,500
-46,500
| -33% | -$2.05M |
|
1714
National Fuel Gas
NFG
$7.67B
| $5.4M | ﹤0.01% |
107,714
-31,338
| -23% | -$1.62M |
|
1715
PUT
CRISPR Therapeutics
CRSP
$4.6B
| $5.4M | ﹤0.01% |
86,300
+76,300
| +763% | +$4.22M |
|
1716
CALL
XPeng
XPEV
$12.2B
| $5.39M | ﹤0.01% |
369,500
+154,000
| +71% | +$2.45M |
|
|
PETQ
1717
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $5.38M | ﹤0.01% |
272,608
-19,970
| -7% | -$384K |
|
1718
CALL
Digital Realty Trust
DLR
$72.4B
| $5.38M | ﹤0.01% |
40,000
-37,800
| -49% | -$4.88M |
|
1719
Brighthouse Financial
BHF
$3.63B
| $5.38M | ﹤0.01% |
101,630
-83,316
| -45% | -$4.14M |
|
1720
Upland Software
UPLD
$13.1M
| $5.37M | ﹤0.01% |
126,931
-2,337
| -2% | -$101K |
|
1721
Comstock Resources
CRK
$3.82B
| $5.36M | ﹤0.01% |
606,179
-652,888
| -52% | -$7.06M |
|
1722
LyondellBasell Industries
LYB
$18.9B
| $5.35M | ﹤0.01% |
56,262
-138,242
| -71% | -$12.9M |
|
1723
Kiniksa Pharmaceuticals
KNSA
$4.89B
| $5.34M | ﹤0.01% |
304,605
-12,914
| -4% | -$212K |
|
1724
Oscar Health
OSCR
$8.54B
| $5.34M | ﹤0.01% |
583,573
+225,949
| +63% | +$1.56M |
|
1725
PUT
Match Group
MTCH
$9.05B
| $5.33M | ﹤0.01% |
146,100
+110,500
| +310% | +$3.73M |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.